Detalles de la búsqueda
1.
Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 22(1): 72-80.e4, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442316
2.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Clin Gastroenterol Hepatol
; 22(3): 572-580.e5, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734582
3.
Kinetics of the hepatitis B core-related antigen and treatment responses in chronic hepatitis B patients treated with tenofovir alafenamide.
Hepatol Res
; 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38685853
4.
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
J Gastroenterol Hepatol
; 39(5): 949-954, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291715
5.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480009
6.
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study.
Hepatol Res
; 53(1): 51-60, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136893
7.
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients.
J Viral Hepat
; 29(9): 807-816, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35657138
8.
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma.
BMC Cancer
; 22(1): 912, 2022 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999529
9.
Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Hepatol Res
; 52(3): 235-246, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861090
10.
Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
J Infect Chemother
; 28(9): 1231-1234, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534339
11.
Outcomes of Sequential Therapy With Tenofovir Alafenamide After Long-term Entecavir.
Am J Gastroenterol
; 116(6): 1264-1273, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34074829
12.
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy.
Cancer Sci
; 111(1): 266-278, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31746520
13.
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.
J Gastroenterol Hepatol
; 35(8): 1420-1425, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31950525
14.
Real-world experience of 12-week direct-acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infection.
J Gastroenterol Hepatol
; 35(5): 855-861, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31609495
15.
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
J Gastroenterol Hepatol
; 35(7): 1229-1237, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31881554
16.
Intraprocedurally EOB-MRI/US fusion imaging focusing on hepatobiliary phase findings can help to reduce the recurrence of hepatocellular carcinoma after radiofrequency ablation.
Int J Hyperthermia
; 37(1): 1149-1158, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996799
17.
Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naïve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan.
J Viral Hepat
; 26(11): 1266-1275, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278795
18.
Circulating microRNA-1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma.
Hepatol Res
; 49(7): 810-822, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-30920086
19.
Comparison Between Low Mechanical Index and High Mechanical Index Contrast Modes of Contrast-Enhanced Ultrasonography: Evaluation of Perfusion Defects of Hypervascular Hepatocellular Carcinomas During the Post-Vascular Phase.
J Ultrasound Med
; 38(9): 2329-2338, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653696
20.
Enhancement of radiofrequency ablation of the liver combined with transarterial embolization using various embolic agents.
Abdom Imaging
; 40(6): 1821-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25526685